Alexis Practical Tactical ETF LEXI 深 沪
已收盘 08-29 16:00:00 美东时间
33.3802
-0.198
-0.59%
华盛通- 最 高33.53
- 今 开33.36
- 成交量 8056股
- 最 低 33.36
- 昨 收 33.5779
- 总市值 1.24亿
- 52周最高 33.60
- 市盈率 静 --
- 换手率 0.22%
- 52周最低 26.055
- 委 比 0.00%
- 总股本 372.68万
- 历史最高 33.60
- 量 比 0.93
- 振 幅 0.51%
- 历史最低 19.983
- 每 手 1
- 风险率 1.39%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Lexicon Pharmaceuticals to Participate at Two Upcoming Investor Conferences
Lexicon Pharmaceuticals, Inc. announced that its management will participate in fireside chats at Citi's Biopharma Back to School Conference on September 3 at 1:45 p.m. ET and at the H.C. Wainwright Global Investment Conference on September 8 at 3:00 p.m. ET. The live events and replays can be accessed via the Company’s website. Lexicon, a biopharmaceutical company, focuses on pioneering medicines through its Genome5000 program, targeting disease...
08-27 12:30
Keros Therapeutics Reveals The FDA Granted Orphan Drug Designation For KER-065 For The Treatment Of Duchenne Muscular Dystrophy
LEXINGTON, Mass., Aug. 20, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. ("Keros") (NASDAQ:KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a
08-20 21:50
Keros Therapeutics Announces Strategic Realignment To Reallocate Resources Towards Development Of Its Key Clinical Program, KER-065; Discontinues Development of Cibotercept (KER-012)
Company Discontinuing Development of Cibotercept (KER-012)Announces Board and Leadership Changes Designed to Support Streamlined Operational Structureand Strategic RealignmentLEXINGTON, Mass., Aug. 06, 2025 (GLOBE
08-07 04:59
Valvoline Inc. Reports Third Quarter Results
Delivers sales of $439 million with strong profit growth; Adds 46 new stores LEXINGTON, Ky., Aug. 6, 2025 /PRNewswire/ -- Valvoline Inc. (NYSE: VVV), the quick, easy, trusted leader in prev...
08-06 19:00
Curis Provides Second Quarter 2025 Business Update
Management to host conference call and webcast today at 8:30 a.m. ET LEXINGTON, Mass., Aug. 5, 2025 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the develop...
08-05 20:00
Lexicon Pharmaceuticals to Report Second Quarter 2025 Financial Results on August 6, 2025
Lexicon Pharmaceuticals announced they will release their second quarter 2025 financial results on August 6, 2025, followed by a conference call and webcast at 8:30 a.m. ET. The webcast and archived version will be available on their website.
07-23 12:00
Valvoline Inc. Releases Its Fiscal Year 2024 Impact Report
LEXINGTON, Ky., July 15, 2025 /PRNewswire/ -- Valvoline Inc. (NYSE: VVV), the quick, easy, trusted leader in preventive automotive maintenance, today announced the release of its Impact Repo...
07-15 19:00
Update on Independent Preliminary Economic Assessment Report from Fluor Corporation
LEXINGTON, Ky., July 8, 2025 /PRNewswire/ -- Ramaco Resources, Inc. (NASDAQ: METC, METCB) ("Ramaco" or the "Company") announces that on July 9 it will receive the Preliminary Economic Assess...
07-09 04:30
Lithium Energi Exploration Issues Retraction Notice
Lithium Energi Exploration ( ($TSE:LEXI) ) has shared an update. Lithium Energi...
05-14 07:39
Lithium Energi Exploration Faces Asset Seizure Amid Debt Settlement
The latest announcement is out from Lithium Energi Exploration ( ($TSE:LEXI) )....
05-14 06:41
